UroGen Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
CEOElizabeth Barrett
CEOElizabeth Barrett
Employees235
Employees235
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2004
Founded2004
Employees235
Employees235
URGN Key Statistics
Market cap899.37M
Market cap899.37M
Price-Earnings ratio-5.86
Price-Earnings ratio-5.86
Dividend yield—
Dividend yield—
Average volume877.64K
Average volume877.64K
High today$19.97
High today$19.97
Low today$19.05
Low today$19.05
Open price$19.84
Open price$19.84
Volume1.04M
Volume1.04M
52 Week high$21.02
52 Week high$21.02
52 Week low$3.42
52 Week low$3.42
URGN News
TipRanks 5d
UroGen Pharma initiated with an Overweight at Piper SandlerPiper Sandler initiated coverage of UroGen Pharma (URGN) with an Overweight rating and $36 price target Elevate Your Investing Strategy: Take advantage of Tip...
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.